BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25106058)

  • 1. Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis.
    Zurita-Turk M; Del Carmen S; Santos AC; Pereira VB; Cara DC; Leclercq SY; de LeBlanc Ad; Azevedo V; Chatel JM; LeBlanc JG; Miyoshi A
    BMC Biotechnol; 2014 Aug; 14():73. PubMed ID: 25106058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactococcus lactis carrying the pValac eukaryotic expression vector coding for IL-4 reduces chemically-induced intestinal inflammation by increasing the levels of IL-10-producing regulatory cells.
    Souza BM; Preisser TM; Pereira VB; Zurita-Turk M; de Castro CP; da Cunha VP; de Oliveira RP; Gomes-Santos AC; de Faria AM; Machado DC; Chatel JM; Azevedo VA; Langella P; Miyoshi A
    Microb Cell Fact; 2016 Aug; 15(1):150. PubMed ID: 27576902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of intestinal inflammation in IL-10 deficient mice by a plasmid carrying Lactococcus lactis strain.
    Zurita-Turk M; Mendes Souza B; Prósperi de Castro C; Bastos Pereira V; Pecini da Cunha V; Melo Preisser T; Caetano de Faria AM; Carmona Cara Machado D; Miyoshi A
    BMC Biotechnol; 2020 Jul; 20(1):38. PubMed ID: 32703192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive Lactococcus lactis producing mycobacterial Hsp65 ameliorates intestinal inflammation in acute TNBS-induced colitis in mice by increasing the levels of the cytokine IL-10 and secretory IgA.
    da Cunha VP; Preisser TM; Santana MP; Machado DCC; Pereira VB; Miyoshi A
    J Appl Microbiol; 2020 Nov; 129(5):1389-1401. PubMed ID: 32473073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant
    Preisser TM; da Cunha VP; Santana MP; Pereira VB; Cara DC; Souza BM; Miyoshi A
    J Diabetes Res; 2021; 2021():6697319. PubMed ID: 33604389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.
    Foligne B; Dessein R; Marceau M; Poiret S; Chamaillard M; Pot B; Simonet M; Daniel C
    Gastroenterology; 2007 Sep; 133(3):862-74. PubMed ID: 17678918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model.
    del Carmen S; Martín Rosique R; Saraiva T; Zurita-Turk M; Miyoshi A; Azevedo V; de Moreno de LeBlanc A; Langella P; Bermúdez-Humarán LG; LeBlanc JG
    J Clin Gastroenterol; 2014; 48 Suppl 1():S12-7. PubMed ID: 25291117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterial Hsp65 antigen delivered by invasive Lactococcus lactis reduces intestinal inflammation and fibrosis in TNBS-induced chronic colitis model.
    da Cunha VP; Preisser TM; Santana MP; Machado DCC; Pereira VB; Miyoshi A
    Sci Rep; 2020 Nov; 10(1):20123. PubMed ID: 33208841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral delivery of Lactococcus lactis that secretes bioactive heme oxygenase-1 alleviates development of acute colitis in mice.
    Shigemori S; Watanabe T; Kudoh K; Ihara M; Nigar S; Yamamoto Y; Suda Y; Sato T; Kitazawa H; Shimosato T
    Microb Cell Fact; 2015 Nov; 14():189. PubMed ID: 26608030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal delivery of Lactococcus lactis carrying an anti-TNF scFv expression vector ameliorates experimental colitis in mice.
    Chiabai MJ; Almeida JF; de Azevedo MGD; Fernandes SS; Pereira VB; de Castro RJA; Jerônimo MS; Sousa IG; de Souza Vianna LM; Miyoshi A; Bocca AL; Maranhão AQ; Brigido MM
    BMC Biotechnol; 2019 Jun; 19(1):38. PubMed ID: 31238939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci.
    Bermúdez-Humarán LG; Motta JP; Aubry C; Kharrat P; Rous-Martin L; Sallenave JM; Deraison C; Vergnolle N; Langella P
    Microb Cell Fact; 2015 Feb; 14():26. PubMed ID: 25889561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventative delivery of IL-35 by Lactococcus lactis ameliorates DSS-induced colitis in mice.
    Wang J; Tian M; Li W; Hao F
    Appl Microbiol Biotechnol; 2019 Oct; 103(19):7931-7941. PubMed ID: 31456001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the anti-inflammatory effect of milk fermented by a strain of IL-10-producing Lactococcus lactis using a murine model of Crohn's disease.
    del Carmen S; de Moreno de LeBlanc A; Perdigon G; Bastos Pereira V; Miyoshi A; Azevedo V; LeBlanc JG
    J Mol Microbiol Biotechnol; 2011; 21(3-4):138-46. PubMed ID: 22286041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.
    Martín R; Chain F; Miquel S; Natividad JM; Sokol H; Verdu EF; Langella P; Bermúdez-Humarán LG
    Hum Vaccin Immunother; 2014; 10(6):1611-21. PubMed ID: 24732667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.
    Steidler L; Hans W; Schotte L; Neirynck S; Obermeier F; Falk W; Fiers W; Remaut E
    Science; 2000 Aug; 289(5483):1352-5. PubMed ID: 10958782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory effects of different strains of Lactococcus lactis in DSS-induced colitis.
    Alves JL; Lemos L; Rodrigues NM; Pereira VB; Barros PAV; Canesso MCC; Guimarães MAF; Cara DC; Miyoshi A; Azevedo VA; Maioli TU; Gomes-Santos AC; Faria AMC
    Braz J Microbiol; 2023 Jun; 54(2):1203-1215. PubMed ID: 36821043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice.
    Nishitani Y; Tanoue T; Yamada K; Ishida T; Yoshida M; Azuma T; Mizuno M
    Int Immunopharmacol; 2009 Nov; 9(12):1444-51. PubMed ID: 19733697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of Fibronectin Binding Protein A at the surface of Lactococcus lactis increases plasmid transfer in vitro and in vivo.
    Pontes D; Innocentin S; Del Carmen S; Almeida JF; Leblanc JG; de Moreno de Leblanc A; Blugeon S; Cherbuy C; Lefèvre F; Azevedo V; Miyoshi A; Langella P; Chatel JM
    PLoS One; 2012; 7(9):e44892. PubMed ID: 23028664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dextran sulphate sodium colitis in C57BL/6J mice is alleviated by Lactococcus lactis and worsened by the neutralization of Tumor necrosis Factor α.
    Berlec A; Perše M; Ravnikar M; Lunder M; Erman A; Cerar A; Štrukelj B
    Int Immunopharmacol; 2017 Feb; 43():219-226. PubMed ID: 28039805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Delivery of Mouse β-Defensin 14 (mBD14)-Producing
    Tian H; Li J; Chen X; Ren Z; Pan X; Huang W; Bhatia M; Pan LL; Sun J
    J Agric Food Chem; 2023 Apr; 71(13):5185-5194. PubMed ID: 36943701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.